Hypertonic Saline to Reduce Hospital Admissions in Bronchiolitis
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Inhaled 3% hypertonic saline (HS) administered every 2-8 hours to infants admitted to
hospital with viral bronchiolitis has been shown to improve airway clearance and reduces
length of stay.
Hypothesis: When infants first present to the ER, frequent administration of HS over a brief
time period will provide significant symptom improvement such that the need for hospital
admission will be reduced.
Objective: To determine in a randomized, controlled and double-blind fashion if the short
term intensive use of inhaled 3% hypertonic saline (HS) in the Emergency Room (ER) can reduce
the rate of hospital admission for infants presenting with moderately severe viral
bronchiolitis.
Phase:
Phase 2
Details
Lead Sponsor:
Queen's University
Collaborators:
Kingston General Hospital Kingston Health Sciences Centre Religious Hospitallers of Saint Joseph of the Hotel Dieu of Kingston Royal Victoria Hospital Of Barrie